Filing metadata

Accession number
0001415889-22-005633
Form type
Form 4
Filer
Theravance Biopharma, Inc.
CIK
CIK 1583107
Filed
May 24, 2022
Reporting period
May 20, 2022
Description
Insider transaction

Explore SEC Filings Hub